The Efficacy and Safety of Janus Kinase Inhibitors for Patients With COVID-19: A Living Systematic Review and Meta-Analysis

The Efficacy and Safety of Janus Kinase Inhibitors for Patients With COVID-19: A Living Systematic Review and Meta-Analysis

BackgroundCytokine storm observed in patients with severe Coronavirus Disease 2019 (COVID-19) contributes to poor clinical outcomes and increased mortality. Janus kinases (JAKs) are important mediators in the cytokine storm. Therefore, we conduct a living systematic review and meta-analysis of the l...

Full description

Bibliographic Details
Main Authors: Xueyang Zhang, Lianhan Shang, Guohui Fan, Xiaoying Gu, Jiuyang Xu, Yeming Wang, Lixue Huang, Bin Cao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Medicine
Subjects:
COVID-19
SARS-CoV-2
Janus kinase inhibitors
baricitinib
systematic review
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.800492/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.800492/full

Similar Items